Rationale and design of the comparison between a P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients undergoing implantation of coronary drug-eluting stents (SMART-CHOICE): A prospective multicenter randomized trial
Conclusions The SMART-CHOICE trial aims to examine the non-inferiority of monotherapy with one of any available oral P2Y12 inhibitors versus conventional DAPT of an identical P2Y12 inhibitor plus aspirin in a broad spectrum of patients receiving representative current-generation DES.
Source: American Heart Journal - Category: Cardiology Source Type: research
More News: Academia | Angioplasty | Aspirin | Bleeding | Cardiology | Chromium | Clopidogrel | Cobalt | Coronary Angioplasty | Heart | Heart Attack | Heart Disease | Percutaneous Coronary Intervention | Plavix | Study | Thrombosis